EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Aptamer-based strategies for glioblastoma: From SELEX to preclinical success

Abdullah Tahir Bayraç

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026

DOI: 10.1016/j.bbcan.2025.189524 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Abdullah Tahir Bayraç. Beteiligte Einrichtung: Department of Bioengineering, Faculty of Engineering, Karamanoğlu Mehmetbey University, Karaman, Türkiye. Electronic address: bayrac@kmu.edu.tr. Hauptthemen laut MEDLINE: Glioblastoma, Aptamers, Nucleotide, SELEX Aptamer Technique, Brain Neoplasms. Die Arbeit nennt 166 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma presents a persistent therapeutic challenge due to extensive intratumoral heterogeneity and the blood-brain barrier. Nucleic acid aptamers offer an effective alternative to overcome these physiological obstacles where conventional modalities often have limited success. This review outlines the progression of aptamers from basic ligands to functional therapeutics, with a focus on targeting glioblastoma stem cells and engineering mechanisms for blood-brain barrier traversal. We discuss how recent biotechnological developments, including Cell-SELEX and AI-supported design, are solving earlier issues related to in vivo stability and conformational selectivity. Additionally, the article evaluates the shift toward multifunctional systems such as aptamer-drug conjugates and "drugtamers" designed for receptor-mediated transport. These advances indicate that next-generation aptamer platforms may overcome current translational limitations and enable more precise neuro-oncological treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaAptamers, NucleotideSELEX Aptamer TechniqueBrain NeoplasmsHumansBlood-Brain BarrierAnimalsNeoplastic Stem Cells

Stichwörter der Autor:innen

AptamerBlood brain barrierDrug deliveryGlioblastomaMolecular targetingSELEX

Substanzen

Aptamers, Nucleotide

Autor:innen und Institutionen

  • Department of Bioengineering, Faculty of Engineering, Karamanoğlu Mehmetbey University, Karaman, Türkiye. Electronic address: bayrac@kmu.edu.tr.

Zitieren

APA

Bayraç, A. T. (2026). Aptamer-based strategies for glioblastoma: From SELEX to preclinical success. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189524

Vancouver

Bayraç AT. Aptamer-based strategies for glioblastoma: From SELEX to preclinical success. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2025.189524

BibTeX
@article{Bayra2026,
  author = {Bayraç, Abdullah Tahir},
  title = {Aptamer-based strategies for glioblastoma: From SELEX to preclinical success},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  doi = {10.1016/j.bbcan.2025.189524}
}
Kostenlos starten →